Hormonal life in systemic lupus and other connective tissue diseases;Lupus et autres connectivites et vie hormonale

Gynecologie Obstetrique et Fertilite

Volumn 31, Issue 9, 2003, Pages 746-756

  Meyer, O ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Antiphospholipid syndrome; Polymyositis; Pregnancy; Systemic lupus erythematosus; Systemic sclerosis

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; CLOMIFENE CITRATE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYPROTERONE ACETATE; DALTEPARIN; ENOXAPARIN; HEPARIN DERIVATIVE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; VITAMIN D;

AGE DISTRIBUTION; ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; CONGENITAL HEART DISEASE; CONNECTIVE TISSUE DISEASE; CONTRACEPTION; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; FETUS DEATH; HEART BLOCK; HORMONE ACTION; HUMAN; HYPERTENSION; KIDNEY FAILURE; NEWBORN MORBIDITY; POLYARTERITIS NODOSA; POLYMYOSITIS; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY; PROGNOSIS; PUERPERIUM; REVIEW; SEX RATIO; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

EID: 0141571298     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/S1297-9589(03)00203-0     Document Type: Short Survey

References (63)

1. Le Thi Huong D, Wechsler B, Piette JC. Influence de la grossesse, de la ménopause et du traitement hormonal substitutif sur l'évolution du lupus érythémateux disséminé. Presse med 2000;29:55-60.
2. Petri M. Exogenous estrogen in systemic lupus erythematosus: oral contraceptives and hormone replacement therapy. Lupus 2001;10:222-6.
3. Sanchez-Guerrero J, Karlson EW, Liang MH, Hunter DJ, Speizer FE, Colditz GA. Past use of oral contraceptives and the risk of developing systemic lupus erythematosus. Arthritis Rheum 1997;40:804-8.
4. Petri M, Robinson C. Oral contraceptives and systemic lupus erythematosus. Arthritis Rheum 1997;40:797-803.
5. Rovensky J, Jurankova E, Rauova L, Blazickova S, Lukac J, Veselkova Z, Jezova D, Vigas M. Relationship between endocrine, immune and clinical variables in patients with systemic lupus erythematosus. J Rheumatol 1997;24:2330-4.
6. Alvarez-Nemegyei J, Cobarrubias-Cobos A, Escalente-Triay F, Sosa-Munoz J, Miranda JM, Jara LJ. Bromocriptine in sytemic lupus erythematosus - a double-blind-randomized, placebo-controlled study. Lupus 1998;7:414-9.
7. Wechsler B, Le Thi Huong D. Ménopause et maladies systémiques. Rev Med Interne 2000;21(suppl 4):478-81.
8. Sanchez Guerrero J, Liang MH, Karlson EW, Hunter DJ, Clditz GA. Postenopausal estrogen therapy and the risk for developing systemic lupus erythematosus (SLE). Ann Intern Med 1995;122:430-3.
9. Meier CR, Sturkenboom MCJM, Cohen AS, Jick H. Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J Rheumatol 1998;25:1515-9.
10. Sanchez-Guerrero J, Villegas A, Mendoza-Fuentes A, Romero-Diaz J, Moreno-Coutino G, Cravioto C. Disease activity during the premenopausal and postmenopausal periods in women with systemic lupus erythematosus. Am J Med 2001;111:464-8.
11. Mok CC, Wong RWS, Lau CS. Ovarian failure and flares of systemic lupus erythematosus. Arthritis Rheum 1999;42:1274-80.
12. Mok CC, Lau CS, Ho CTK, Wong RWS. Do flares of systemic lupus erythematosus decline after menopause? Scand J Rheumatol 1999;28:357-62.
13. Arden NK, Lloyd ME, Spector TD, Hughes GRV. Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE). Lupus 1994;3:11-3.
14. Buyon JP, Kalunian KC, Skovron ML, Petri M, Lahita R, Merrill J, et al. Can women with systemic lupus erythematosus safely use exogenous estrogens? J Clin Rheumatol 1995;1:205-12.
15. Kreidstein S, Urowitz MB, Gladman DD, Gough J. Hormone replacement therapy in systemic lupus erythematosus. J Rheumatol 1997;24:2149-52.
16. Mok CC, Lau CS, Ho CTK, Lee KW, Mok MY, Wong RWS. Safety of hormonal replacement therapy in postmenopausal patients with systemic lupus erythematosus. Scand J Rheumatol 1998;27:342-6.
17. Petri MA, Lahita RG, van Vollenhoven RF, Merrill JT, Schiff M, Ginzler EM, et al. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus. A double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2002;46:1820-9.
18. Guballa N, Sammaritano L, Schwartzman S, Buyon J, Lockshin MD. Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum 2000;43:550-6.
19. Wechsler B, Le Thi Huong D, Vauthier-Brouzes D, Lefebvre G, Gompel A, Piette JC. Hormone stimulation and replacement therapy in women with rheumatic disease. Can we advise ovulation induction in patients with SLE? Scand J Rheumatol 1998;27(suppl 107):53-9.
20. Khamashta MA, Ruiz-Irastorza G, Hughes GRV. Systemic lupus erythematosus flares during pregnancy. Rheum Dis Clin North America 1997;23:15-30.
21. Le Thi Huong D, Wechsler B, Vauthier-Brouzes D, Seebacher J, Lefebvre G, Bletry O. Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies. Br J Rheumatol 1997;36:772-7.
22. Lockshin MD, Reinitz E, Druzin ML, Murmann M, Estes D. Lupus pregnancy. I Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med 1984;77:893-8.
23. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins lupus pregnancy center experience. Arthritis Rheum 1991;34:1538-45.
24. Petri M. Hopkins lupus pregnancy center: 1987 to 1996. Rheum Dis Clin North America 1997;23:1-13.
25. Branch DW, Peaceman AM, Druzin M, et al. Multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol 2000:122-82.
26. Parke A, West B. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus. J Rheumatol 1996;23:1715-8.
27. Buchanan NM, Toubi E, Khamashta MA, Lima F, Kerslake S, Hughes GRV. Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases. An n Rheum Dis 1996;55:486-8.
28. Wechsler B, Le Thi Huong D, Piette JC. Grossesse et lupus érythémateux systémique. Ann Med interne 1999;150:408-18.
29. Estes D, Larson DL. Systemic lupus erythematosus and pregnancy. Clin Obstet Gynecol 1995;8:307-12.
30. Packham DK, Lam SS, Nicholls K, Fairley KF, Kincaid-Smith PS. Lupus nephritis and pregnancy. Q J Med 1992;83:315-24.
31. Oviasu E, Hicks J, Cameron JS. The outcome of pregnancy in women with lupus nephritis. Lupus 1991;1:19-25.
32. Julkunen H, Kaaja R, Palosuo T, Gronhagen Riska C, Teramo K. Pregnancy in lupus nephropathy. Acta Obstet Gynecol Scand 1993;72:258-63.
33. Le Thi Huong D, Wechsler B, Piette JC, Vauthier-Brouzes D, Seebacher J, Lefebvre G, et al. Programme de planification de la grossesse au cours du lupus érythémateux disséminé. Presse med 1996;25:711-7.
34. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirine alone. Am J Obstet Gynecol 1996;174:1584-9.
35. Ruiz Irastorza G, Khamashta MA, Hugues GRV. Heparin and osteoporosis during pregnancy: 2002 update. Lupus 2002;11:680-2.
36. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Brit Med J 1997;314:253-7.
37. Welsch S, Branch W. Antiphospholipid syndrome in pregnancy. Obstetric concerns and treatment. Rheum Dis Clin North America 1997;23:71-84.
38. Le Thi Huong D, Wechsler B, Edelman P, Fournie A, Le Tallec Y, Piette JC, et al. Post-partum cerebral infarction associated with aspirine withdrawal in the antiphospholipid antibody syndrome. J Rheumatol 1993;20:1229-32.
39. Le Thi Huong D, Wechsler B, Piette JC, Bletry O, le Groupe d'Étude sur la Grossesse Lupique. Registre français des grossesses lupiques. Le bilan. Rev Med Interne 1994;15:305-17.
40. Petri M. Pregnancy in SLE. Baillière Clin Rheumatol 1998;12:449-76.
41. Cooley HM, Keech CL, Melny BJ, Menahem S, Morahan G, Kay TWH. Monozygotic twins discordant for congenital complete heart block. Arthritis Rheum 1997;40:381-4.
42. Tseng CE, Buyon JP. Neonatal lupus syndromes. Rheum Dis Clin North America 1997;23:31-49.
43. Mavragani CP, Dafni UG, Tzioufas AG, Moutsopoulos HM. Pregnancy outcome and anti-Ro/SSA in autoimmune diseases: a retrospective cohort study. Brit J Rheumatol 1998;37:740-5.
44. Mavragani CP, Ioannidis JPA, Tzioufas AG, Hantoumi IE, Moutsopoulos HM. Recurrent pregnancy loss and autoantibody profile in autoimmune diseases. Rheumatology 1999;38:1228-33.
45. Saleeb S, Copel J, Friedman D, Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody associated congenital heart block. Arthritis Rheum 1999;42:2335-45.
46. Cuadrado MJ, Hughes GRV. Hughes (antiphospholipid) syndrome. Clinical features. Rheumatic Dis Clin 2001;27:507-24.
47. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. New Engl J Med 2002;346:752-63.
48. Shehata HA, Nelson-Piercy C, Khamashta MA. Management of pregnancy in antiphospholipid syndrome. Rheumatic Dis Clin 2001;27:643-59.
49. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JCH, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop. Arthritis Rheum 1999;42:1309-11.
50. Rand JH, Wu XX, Andree HA, Lockwoos CH, Gullier S, Scher J, et al. Pregnancy in the antiphospholipid antibody syndrome: a possible thrombogenic mechanism. N Engl J Med 1997;337:154-60.
51. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992;166:1318-23.
52. Kutteh WH, Ermel LD. A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol 1996;35:402-7.
53. Backos M, Rai R, Baxter N, Chilcott IT, Cohen H, Regan L. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Brit J Obstet Gynaecol 1999;106:102-7.
54. Harris EN. Management of the antiphospholipid syndrome. In: Van de Putte LB, Furst DE, Williams HS, Van Riel PL, editors. Therapy of systemic rheumatic diseases. New York: Marcel Dekker; 1998. p. 629-56.
55. Steen VD. Scleroderma and pregnancy. Rheum Dis North America 1997;23:133-47.
56. Steen VD, Medsger TA. Fertility and pregnancy outcome in women with systemic sclerosis. Arthritis Rheum 1999;42:763-8.
57. Gutierrez G, Dagnino R, Mintz G. Polymyositis/dermatomyositis and pregnancy. Arthritis Rheum 1984;27:291-4.
58. Cavazzana I, Franceschini F, Belfiore N, Auinzanini M, Caporali R, Calzavara-Pinton P, et al. Undifferenciated donnective tissue disease with antibodies to Ro/SSA: clinical features and follow-up of 148 patients. Clin Exp Rheumatol 2001;19:403-9.
59. Manthorpe T, Manthorpe R. Congenital complete heart block in children of mothers with primary Sjögren's syndrome. Lancet 1992;340:1359-60.
60. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by coutterimmunoelectrophoresis. A prospective study of 100 women. Arthritis Rheum 2001;44:1832-5.
61. Press J, UZiEL Y, Lawer RM, Luy L, Hamilton RM, Silverman ED, Long-term outcome of mothers of children with complete congenital heart block. Amer J Med 1996;100:328-32.
62. Papo T, Wechsler B, Bletry O, Piette AM, Godeau P, Piette JCH. Pregnancy in relapsing polychondritis: twenty-five pregnancies in eleven patients. Arthritis Rheum 1997;40:1245-9.
63. Auzary C, Le Thi Huong D, Wechsler B, Vauthier-Brouzes, Piette JCH. Pregnancy in patients with Wegener's granulomatosis: report of five cases in three women. Ann Rheum Dis 2000;59:800-3.